Screener
Indivior Pharmaceuticals, Inc. INDV EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s EV / EBITDA?
- Indivior Pharmaceuticals, Inc. (INDV) reported EV / EBITDA of 11.8× in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s EV / EBITDA changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s EV / EBITDA decreased by 57.1% year-over-year, from 27.6× to 11.8×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Indivior Pharmaceuticals, Inc.'s ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude